523 related articles for article (PubMed ID: 17032878)
1. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
Law M; Young R; Babb J; Pollack E; Johnson G
AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.
Cha S; Yang L; Johnson G; Lai A; Chen MH; Tihan T; Wendland M; Dillon WP
AJNR Am J Neuroradiol; 2006 Feb; 27(2):409-17. PubMed ID: 16484420
[TBL] [Abstract][Full Text] [Related]
6. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
[TBL] [Abstract][Full Text] [Related]
8. Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.
Mills SJ; Soh C; O'Connor JP; Rose CJ; Buonaccorsi G; Cheung S; Zhao S; Parker GJ; Jackson A
AJNR Am J Neuroradiol; 2010 Apr; 31(4):726-31. PubMed ID: 20019100
[TBL] [Abstract][Full Text] [Related]
9. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
10. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
12. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.
Jackson A; Kassner A; Annesley-Williams D; Reid H; Zhu XP; Li KL
AJNR Am J Neuroradiol; 2002 Jan; 23(1):7-14. PubMed ID: 11827869
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
[TBL] [Abstract][Full Text] [Related]
16. Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.
Di Stefano AL; Bergsland N; Berzero G; Farina L; Rognone E; Gastaldi M; Aquino D; Frati A; Tomasello F; Ceroni M; Marchioni E; Bastianello S
Biomed Res Int; 2014; 2014():154350. PubMed ID: 24800207
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma.
Bastin ME; Carpenter TK; Armitage PA; Sinha S; Wardlaw JM; Whittle IR
AJNR Am J Neuroradiol; 2006 Feb; 27(2):402-8. PubMed ID: 16484419
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.
Yang S; Law M; Zagzag D; Wu HH; Cha S; Golfinos JG; Knopp EA; Johnson G
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1554-9. PubMed ID: 13679270
[TBL] [Abstract][Full Text] [Related]
19. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
20. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.
Emblem KE; Scheie D; Due-Tonnessen P; Nedregaard B; Nome T; Hald JK; Beiske K; Meling TR; Bjornerud A
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1664-70. PubMed ID: 18583405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]